Separation of the Cell Envelope for Gram-negative Bacteria into Inner and Outer Membrane Fractions with Technical Adjustments for Acinetobacter baumannii

Summary

Gram-negative bacteria produce two spatially segregated membranes. The outer membrane is partitioned from the inner membrane by a periplasm and a peptidoglycan layer. The ability to isolate the dual bilayers of these microbes has been critical for understanding their physiology and pathogenesis.

Abstract

This method works by partitioning the envelope of Gram-negative bacteria into total, inner, and outer membrane (OM) fractions and concludes with assays to assess the purity of the bilayers. The OM has an increased overall density compared to the inner membrane, largely due to the presence of lipooligosaccharides (LOS) and lipopolysaccharides (LPS) within the outer leaflet. LOS and LPS molecules are amphipathic glycolipids that have a similar structure, which consists of a lipid-A disaccharolipid and core-oligosaccharide substituent. However, only LPS molecules are decorated with a third subunit known as the O-polysaccharide, or O-antigen. The type and amount of glycolipids present will impact an organism’s OM density. Therefore, we tested whether the membranes of bacteria with varied glycolipid content could be similarly isolated using our technique. For the LPS-producing organisms, Salmonella enterica serovar Typhimurium and Escherichia coli, the membranes were easily isolated and the LPS O-antigen moiety did not impact bilayer partitioning. Acinetobacter baumannii produces LOS molecules, which have a similar mass to O-antigen deficient LPS molecules; however, the membranes of these microbes could not initially be separated. We reasoned that the OM of A. baumannii was less dense than that of Enterobacteriaceae, so the sucrose gradient was adjusted and the membranes were isolated. The technique can therefore be adapted and modified for use with other organisms.

Introduction

Gram-negative bacteria produce two membranes that are separated by a periplasmic space and a peptidoglycan cell wall¹. The inner membrane (IM) encases the cytosol and is a symmetric bilayer of phospholipids. Peptidoglycan protects against turgor pressure and provides the bacterium with a cell shape, and is attached to the outer membrane (OM) by lipoproteins^2,3. The OM surrounds the periplasm and is predominantly asymmetric. The inner leaflet consists of phospholipids and the outer leaflet consists of glycolipids known as lipooligosaccharides (LOS) or lipopolysaccharides (LPS)^4,5. The lipid asymmetry and the biochemistry of the LOS/LPS molecules in the outer leaflet confer barrier properties to the cell surface that protect the bacterium against hazards in its environment^6,7.

LPS molecules are comprised of three constituents: the lipid A disaccharolipid, the core oligosaccharide, and the O-polysaccharide or O-antigen. Lipid A is a multiply acylated disaccharolipid. Core-oligosaccharides consist of 10–15 sugars known as rough LPS or R-LPS. The core is subdivided into the inner region, composed of 2-keto-3-deoxy-D-manno-octulosonic acid (kdo) and one or more heptose residues, and an outer region that consists generally of hexoses (glucose or galactose) and heptoses, or acetamido sugars⁵. The outer core region is more variable in its components and structure than the inner core. In Salmonella spp., only one core structure has been described; however, in Escherichia coli there are five different core structures (designated K-12, R1, R2, R3, and R4)⁸. E. coli K-12 DH5α, which we use in this procedure carries a mutation that results in production R-LPS⁹. The R-LPS molecules lack the O-antigen moiety and have a similar molecular weight to LOS molecules.

The addition of O-antigen to R-LPS turns this molecule into smooth LPS, or S-LPS. The O-antigens are built from short 3-4 carbohydrate subunits and consist of multiple modalities with varying chain lengths¹⁰. Some LPS-producing bacteria, like Salmonella enterica serovar Typhimurium (S. Typhimurium), display a trimodal distribution of LPS molecules on their surface^10,11. Very-long chain O-antigens can contain over one hundred subunits and weigh over one hundred kilodaltons. The O-antigens provide surface properties to the bacterium that are necessary to resist antibiotics, evade predation by bacteriophages, and cause disease.

Species of Campylobacter, Bordetella, Acinetobacter, Haemophilus, Neisseria and others generate LOS molecules instead of LPS molecules on their surface¹². LOS molecules consist of lipid A and core oligosaccharides but lack the O-antigen. These types of Gram-negative bacteria modify their core oligosaccharides with additional sugars and combinations of sugars to alter surface properties¹². Both LOS and LPS-producing microbes derivatize the phosphates on lipid A and core molecules with cationic moieties⁷. These additions include phosphoethanolamine, galactosamine and aminoarabinose substitutions, which function by neutralizing anionic surface charge and thereby protecting against cationic antimicrobial peptides. Gram-negative bacteria also modify the core oligosaccharide structure with variable non-stoichiometric substitutions of sugars, or extra kdo molecules, and alter the number of acyl chains on lipid-A disaccharolipids⁷.

The ability to isolate the IM from the OM of Gram-negative bacteria has been instrumental for understanding the role of the cell envelope in antimicrobial resistance and disease pathogenesis^11,12. Derivations of this approach have been used to deduce mechanisms of assembly, maintenance, and remodeling of the protein, phospholipid, and glycolipid constituents for the OM.

Our lab routinely performs bacterial lipidomic analyses to study protein-mediated lipid regulation and lipid function in a variety of Gram-negative species. The volumes used in the protocol reflect the routine use of this procedure to analyze non-radiolabeled phospholipids by thin layer chromatography and liquid chromatography tandem mass spectrometry^13,14.

The protocol begins by exposing a chilled suspension of Gram-negative bacteria to a high osmolar solution of sucrose and adding lysozyme to dissociate the OM from the underlying peptidoglycan layer (Figure 1)¹². EDTA is then added to facilitate penetration of the lysozyme, since divalent cation sequestration disrupts the lateral electrostatic bridging interactions between adjacent LOS/LPS molecules¹⁵. The original protocol from which ours has been adapted required the formation of spheroplasts, a Gram-negative bacterial cell form that consist of a plasma membrane and cytosol, but lacks the peptidoglycan layer and an OM. It is possible that spheroplasts are produced by the adapted method; however, the technique does not rely or intend on their formation for success. Instead, the lysozyme-EDTA treated bacteria are rapidly harvested by centrifugation and re-suspended in a sucrose solution of lesser concentration before pressurized lysis. The OMs that might have been released by forming spheroplasts should in theory be harvestable from the supernatants of the treated cells, but this approach is not detailed herein. Ultimately, the treated cells are subjected to conventional homogenization and lysis, which enhances the efficiency and reproducibility of the membrane separation procedure¹⁶.

After lysis, the total membranes are collected by ultracentrifugation and applied to a discontinuous sucrose density gradient to fractionate the IMs and OMs. The classical approach uses a more continuous gradient that consists of at least five different sucrose solutions^11,12. The discontinuous gradient in our protocol consists of three sucrose solutions and partitions the bilayers into two distinct fractions¹⁷. The LOS and LPS molecules within the OMs of Gram-negative bacteria drive the envelope to partition into an upper brown low-density IM fraction and a lower white high-density OM fraction (Figure 1 and Figure 2).

Acinetobacter baumannii are important multidrug resistant human pathogens that produce LOS molecules in their OM and erect a cell envelope that is difficult to separate^18,19. Recent work suggests that a derivation of the protocol we present here can be used to partition the bilayers of these organisms²⁰. Therefore, we tested our protocol on A. baumannii 17978. Initially, the procedure was inadequate. However, we modified the sucrose concentration of the middle density solution and greatly improved separation (Figure 2). An NADH dehydrogenase assay and a LOS/LPS extraction and detection procedure was used to confirm separation for A. baumannii, wild-type S. Typhimurium and two O-antigen deficient enterobacterial genotypes; namely, galE-mutant S. Typhimurium and a laboratory strain, E. coli DH5α (Figure 3 and Figure 4).

The intent of this work is to supply a streamlined approach for reproducibly isolating the membranes of Gram-negative bacteria. The protocol can be used to study many types of membrane-associated molecules for these microbes.

Protocol

1. General Reagents and Media Preparation for Membrane Extraction

1. Bacterial growth media: Prepare and sterilize 1 L of broth media in a thoroughly cleaned and autoclaved 2 L flask.
2. General resuspension buffer (1 M Tris Buffer pH 7.5; 50 mL): Dissolve 6.05 g of Tris base in 30 mL of H₂O. Adjust pH to 7.5 with 5 M HCl. Adjust final volume to 50 mL with ultrapure H₂O.
3. Master stock of divalent cation chelation solution (0.5 M EDTA pH 8; 100 mL): Add 18.6 g of disodium ethylene tetraacetate·2H₂O to 80 mL of H₂O. Stir vigorously and adjust pH to 8.0 with NaOH. Adjust final volume to 100 mL with ultrapure H₂O.
   NOTE: The disodium salt of EDTA will not dissolve until the pH of the solution is adjusted to ~8.0 by the addition of NaOH.
4. Osmotic buffer A (0.5 M sucrose, 10 mM Tris pH 7.5; 1 L): Weigh 171.15 g of sucrose and transfer to a 1 L cylinder. Add 10 mL of 1 M Tris pH 7.5. Adjust to a final volume of 1 L with ultrapure H₂O. Store at 4 °C.
5. Lysozyme (10 mg/mL; 5 mL): Weigh 50 mg of (chicken egg-white) lysozyme and dissolve in 5 mL ultrapure H₂O. Store at 4 °C.
6. Diluted divalent cation chelation solution (1.5 mM EDTA; 500 mL): Add 1.5 mL of 0.5 M EDTA (Step 1.3) to 497.5 mL ultrapure H₂O. Store at 4 °C.
7. Osmotic buffer B (0.2 M sucrose, 10 mM Tris pH 7.5; 2 L): Weigh 136.8 g of sucrose and transfer to a 2 L cylinder. Add 20 mL of 1 M Tris pH 7.5. Adjust final volume to 2 L with ultrapure H₂O. Store at 4 °C.
8. Nuclease co-factor (1 M MgCl₂; 10 mL): Dissolve 2.03 g of MgCl₂·6H₂O in 8 mL of ultrapure H₂O. Adjust volume to 10 mL. Store at room temperature.
9. Nuclease solution cocktail including RNase and DNase enzymes: See Table of Materials. Store at -20 °C.
10. Protease inhibitor cocktail: See Table of Materials. Store at 4 °C.
11. Low-density isopycnic sucrose gradient solution (20% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5 Solution; 100 mL): Weigh 20 g of sucrose and transfer to a 200 mL cylinder. Add 100 µL of 1 M Tris Buffer pH 7.5 and 200 µL of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H₂O. Store at room temperature.
12. Medium-density isopycnic sucrose gradient solution (53% w/v sucrose, 1 mM EDTA, 1mM Tris pH 7.5 Solution; 100 mL): Weigh 53 g of sucrose and transfer to a 200 mL graduated cylinder. Add 100 µL of 1 M Tris Buffer pH 7.5 and 200 µL of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H₂O. Store at room temperature.
    NOTE: Prepare this solution in a graduated cylinder to ensure accuracy due to the high percentage of sucrose. Add a magnetic stir bar and stir until the sucrose is completely dissolved in solution. This process may take several hours.
13. High-density isopycnic sucrose gradient solution (73% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5 Solution; 100 mL): Weigh 73 g of sucrose and transfer to a 200 mL graduated cylinder. Add 100 µL of 1 M Tris Buffer pH 7.5 and 200 µL of 0.5 M EDTA pH 8. Adjust final volume to 100 mL with ultrapure H₂O. Store at room temperature.
    NOTE: Prepare this solution in a graduated cylinder to ensure accuracy due to the high percentage of sucrose. Add a magnetic stir bar and stir until the sucrose is completely dissolved. This process may take several hours.
14. Isolated-membrane-storage buffer (10 mM Tris Buffer pH 7.5; 1 L): Add 1 mL of 1 M Tris Buffer pH 7.5 to a 1 L flask and adjust the final volume to 1 L with ultrapure H₂O.
15. β-Nicotinamide adenine dinucleotide (NADH) (10 mg/mL solution): Resuspend 10 mg of NADH in ultrapure H₂O. Prepare fresh stocks, weekly. Store at -20 °C.
16. Phenol solution equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA: See Table of Materials. Store the solution at 4 °C.
17. Lipopolysaccharide gel stain kit: See Table of Materials.
18. Bradford reagent: See Table of Materials.
    NOTE: All solutions and media should be prepared within the week of performing the assay to ensure consistent results.

2. Preparation of Bacteria for Membrane Extraction

1. Streak the bacteria from frozen glycerol stocks onto fresh agar plates. Store the plates at 4 °C once colonies develop. Inoculate a single colony into a 5 mL tube filled with broth media and culture the bacteria as desired overnight.
2. Back-dilute the overnight bacterial culture into 1 L of preferred broth media and culture the bacteria until the desired optical density is achieved.
   NOTE: Inoculating a single bacterial colony into 1 L of broth media is recommended for mutant genotypes that are prone to suppressing growth phenotypes, but some Gram-negative bacteria simply grow slower than others. If it is not possible to achieve a sufficient culture density by single-colony inoculation, back diluting an overnight culture into 1 L of media is one strategy to synchronize growth. Bacterial-membrane composition varies depending upon the growth phase of the culture (logarithmic vs stationary phase)¹³. Growth curves measuring the change in optical density for the bacterial cultures as a function of time should be performed with all strains to correlate culture density with growth phase.
3. Set the flasks containing the broth cultures on ice. Read the optical density at 600 nm (OD₆₀₀) and calculate the volume of culture that is equivalent to between 6.0 and 8.0 x 10¹¹ bacterial colony forming units (cfu). For S. Typhimurium, this corresponds to 1 L of culture at an OD₆₀₀ of between 0.6-0.8, since an OD₆₀₀ of 1.0 is equal to roughly 1.0x10⁹ cfu/mL. Add this volume to a centrifuge tube and ensure that the remaining cultures stay on ice until they are to be used.
4. Pellet the bacteria by centrifugation at 4 °C at 7,000-10,000 x g in a fixed angle high-speed centrifuge for 10 min.
   NOTE: Pre-cool and maintain the centrifuges at a low temperature. Maintain the samples on ice during the entire procedure.
5. Decant and discard the supernatant carefully.
   NOTE: The pellet can be flash frozen and/or stored at -80 °C if the membrane fractions are not going to be extracted immediately. However, it is recommended to proceed directly with plasmolysis on the same day the cells are harvested, and is especially recommended for non-enterobacterial species.

3. Dissociation of the Outer Membrane and Plasmolysis

1. Thaw the cell pellets on ice if previously stored at -80 °C and retain the samples on ice for the remainder of the procedure. Resuspend each cell pellet within the centrifuge tube in 12.5 mL of buffer A. Add a magnetic stir bar to the suspension of cells.
2. Add 180 µL of 10 mg/mL lysozyme (final concentration of 144 μg/mL) to each cell resuspension. Keep the samples on ice while stirring for 2 min.
3. Add 12.5 mL of 1.5 mM EDTA solution to each cell resuspension and continue stirring on ice for an additional 7 min.
4. Decant the suspension into a 50 mL conical tube and centrifuge at 9,000-11,000 x g for 10 min at 4 °C.
5. Discard supernatants into a biohazard waste container and retain the pellets on ice.
6. Add 25 mL of buffer B to the cell pellet.
7. Add 55 µL of 1 M MgCl₂, 1 µL of RNase/DNase nuclease reagent (to avoid viscosity problems associated with bacteria undergoing plasmolysis prior to homogenization), and 1 µL of protease inhibitor cocktail to the volume of buffer B that sits atop the cell pellet
8. Resuspend the pellet in the buffer B mixture. Vigorously pipet and vortex until observing a homogenous solution.
   NOTE: It is very important to have a homogenous solution before proceeding to Step 4 of this protocol. The resuspended cells should have a viscous cake-batter like appearance and consistency.
9. Vortex each sample for 15 s. Retain suspensions on ice and proceed to Step 4.

4. Pressurized Homogenization and Lysis

NOTE: Several methods can be used for lysis. Sonication is not ideal due to the generation of heat. Osmotic lysis can be achieved but is often inefficient. Therefore, we recommend high-pressure lysis. High pressure lysis can be achieved using a variety of instruments. We suggest homogenization machines, such as the French Press or the Emusliflex. We work with many types of Gram-negative bacteria whose response to high osmolar sucrose solutions varies. The high-pressure homogenization step improves efficiency, reproducibility, and yield.

1. Prechill the French Press cell at 4 °C or insert the metal coil from the homogenizer machine on ice.
2. Pour the sample into the French-pressure cell or the homogenizer-sample cylinder and bring the cell under the desired homogenization pressure (10,000 psi should be adequate when using a French Press or 20,000 psi when using a homogenizer).
3. Adjust the outlet flow rate to approximately one drop per second while maintaining the pressure if utilizing a French Press.
4. Collect the cell lysate in 50 mL conical tubes while keeping samples on ice.
5. Repeat steps 4.2-4.4 three to five times to achieve complete lysis, typically indicated by gradual increase in transparency of sample.
   NOTE: The sample chamber should be washed and equilibrated with Buffer B in between samples.
6. Keep lysed cells on ice.

5. Total Membrane Fractionation

1. Centrifuge the lysed bacterial samples at 6,169 x g for 10 min at 4 °C to pellet remaining intact cell material. (e.g., unlysed bacterial cells).
2. Distribute the remaining portion of the supernatant, which now contains the homogenized membranes into a polycarbonate bottle for ultracentrifugation.
   CAUTION: If needed, cell samples can be balanced by diluting with buffer B.
3. Ultracentrifuge the cell lysates at 184,500 x g for at least 1 h, at 4 °C. This step can be performed overnight without affecting the quality of the membranes.
4. Discard remaining supernatant present in the ultracentrifuge tube and retain membrane pellets on ice (Figure 1).
5. Resuspend the membrane pellets in 1 mL of the low-density isopycnic-sucrose gradient solution using a glass-dounce homogenizer. Use a glass Pasteur pipette to transfer the sample homogenate to a 1.5 mL microcentrifuge tube and retain on ice.
   NOTE: If only total membrane composition analysis is desired, substitute 1 mL of low-density isopycnic-sucrose gradient solution for 1 mL of isolated-membrane storage buffer. Step 5.5 is the endpoint of isolation if only total-bacterial membrane samples are desired. Store samples at -20 °C until further downstream analysis is required.

6. Density Gradient Ultracentrifugation to Separate the Dual Membranes

1. Gather the appropriate number of 13 mL polypropylene or ultra-clear open-top tubes specified for a swinging bucket rotor and ultracentrifuge.
2. Hold the tube in a slightly tilted position and prepare the sucrose gradient by slowly adding sucrose solutions from higher density to lower density in the following order:
   2 mL of 73% w/v sucrose,1 mM EDTA, 1 mM Tris pH 7.5
   4 mL of 53% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5
   1. Next, add the total membrane fraction (1 mL), which has been resuspended in the 20% w/v sucrose solution (step 5.5). Avoid mixing the membrane fraction with the sucrose solution that lies beneath it. Divisions should be visible between each of these layers.
   2. Finally, fill the tube with the low-density isopycnic-sucrose gradient solution (approx. 6 mL). Polypropylene and ultra-clear open-top tubes should be filled as full as possible (2 or 3 mm from the tube top) for tube support.
3. Adjustment for Acinetobacter baumannii 17978
   1. Adapt an adjusted sucrose gradient for use with different bacterial specimens. For A. baumannii, the following sucrose gradient afforded more complete separation of the membranes (Figure 2).
      2 mL of 73% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5
      4 mL of 45% w/v sucrose, 1 mM EDTA, 1 mM Tris pH 7.5
   2. Next, add the total membrane fraction (1 mL), which has been resuspended in the 20% w/v sucrose solution (step 5.5). Avoid mixing the membrane fraction with the sucrose solution that lies beneath it. Divisions should be visible between each of these layers.
   3. Finally, fill the tube with low-density isopycnic-sucrose gradient solution (approx. 6 mL). Polypropylene and ultra-clear open-top tubes should be filled as full as possible (2 or 3 mm from the tube top) for tube support.
4. Ultracentrifuge the samples using a swinging-bucket rotor at 288,000 x g and 4 °C overnight.
   NOTE: For the volumes used in the previous steps, we recommend centrifugation times between 16 h and 23 h.
5. Cut the end of a P1000 pipette tip about 5 mm from the point. Remove the upper-brown IM layer using the pipette. Transfer the IM fraction into a polycarbonate bottle for ultracentrifugation.
6. Leave about 2 mL of the sucrose solution above the 53-73% interface to ensure that the lower white OM is not cross contaminated with the IM fraction. Repeat the pipetting procedure from step 6.4 for the OM fraction (Figure 1).
   NOTE: The membranes can also be collected by puncturing the centrifuge tubes at the bottom using a needle and collecting the membranes as fractions dropwise.
7. Fill the remaining void of the ultracentrifuge tube with isolated-membrane storage buffer and mix by inversion or pipetting. Retain the samples on ice.
8. Collect the now washed and isolated membranes by ultracentrifugation at 184,500 x g for 1 h and 4 °C.
9. Discard the supernatant and resuspend the membranes by dounce-homogenization. Add 500-1000 μL of storage buffer. Collect samples in 2 mL microcentrifuge tubes.
10. Store the bacterial membrane samples at -20 °C.

7. Confirming Separation of the Bilayers

NOTE: Incomplete separation of the bilayers can occur due to technical error or the unique cell envelope composition of some species. To confirm separation, we advise using two independent assays to quantify the degree of cross contamination between the bilayers. The first assay detects the enzymatic activity of NADH dehydrogenase, which exists exclusively in the IM. The second assay detects the presence of LOS or LPS, which predominantly exists in the OM.

1. Confirming that the OMs are isolated from the IMs
   1. Measure the protein concentration in each isolated membrane fraction using a Bradford protein assay.
   2. Add the volume of sample corresponding to between 50 and 500 µg of protein to an empty 2 mL microcentrifuge tube. The concentration will vary depending upon the species, but 50 µg is typically sufficient for Enterobacteriaceae. Add the appropriate volume of 10 mM Tris-buffer to achieve a total volume of 990 μL. Transfer the content to a cuvette for spectrophotometry.
   3. Add 10 μL of a 10 mg/mL solution of NADH to the sample and measure the initial absorbance at 340 nm.
   4. Continue measuring the absorbance every 30 s for 5 min.
   5. Compile the data and graph the change in absorbance (y-axis) vs. the change in time (x-axis) for each membrane fraction (Figure 3).
2. Confirming that the IMs are isolated from the OMs
   1. Add the volume of sample corresponding to between 50 and 500 µg of protein to an empty 2 mL microcentrifuge tube. The concentration will vary depending upon the bacterial species, but 50 µg is typically sufficient for Enterobacteriaceae. Fill to a final volume of 100 μL with phosphate buffered saline, which is hereafter referred to as the aqueous phase.
   2. Add 5 μL of Proteinase K (stock 800 U/mL) to the aqueous phase and incubate overnight at 59 °C.
   3. Warm a 10 mL aliquot of Tris-saturated Phenol for 10 min at 68 °C.
   4. Spin down the aqueous phase samples that were treated with the Proteinase K and add the “hot” Tris-saturated Phenol at a 1:1 ratio with the aqueous phase, vortex vigorously and incubate at 68 °C for 10 min.
   5. Transfer the now milky-white samples from 68 °C to an ice-water bath and incubate for 10 min.
   6. Centrifuge the samples at 2,100 x g for 10 min at 4 °C.
   7. Transfer the upper aqueous phase to a new tube and store the tube at -20 °C if the sample is not to be used immediately.
   8. Dilute samples in SDS-loading buffer and load the wells of a 4-20% Tris-glycine gradient gel.
   9. Electrophorese for 45 min or until the dye-front is at the bottom of the gel.
   10. Stain the gel using the LPS staining kit following manufacturer’s instructions.

Results

This technique provides an effective means to isolate the IMs and OMs for Gram-negative bacteria. An outline of the entire procedure is illustrated (Figure 1). In general, the normalization of cultures to an OD₆₀₀ of 0.6-0.8 in 1 L of media, or harvesting between 6.0 and 8.0 x 10¹¹ bacterial cells will ensure that the appropriate amount of membrane material is collected for subsequent separation.

Upon lysing the bacteria and ultracentrifuging...

Discussion

This method will continue to aid researchers in understanding the role of the cell envelope in bacterial physiology and pathogenesis. Following the sequential ultracentrifugation steps a purified total, inner, and OM fraction can be obtained. These membranes can be assayed in isolation to test hypotheses related to membrane protein localization and function, transport and trafficking across the periplasm, and the composition of the individual bilayers under various environmental conditions. Biological studies exploring t...

Materials

Name	Company	Catalog Number	Comments
1 L Centrifuge bottles, PC/PPCO, super speed, with sealing cap, Nalgene	VWR	525-0466
1 L Pyrex Media Storage Bottle with High Temperature Cap	VWR	10416-312
2,000 mL Erlenmeyer Flask, Narrow Mouth	VWR	10545-844
4-20% mini PROTEAN Precast Protein Gels, 12 well	BIORAD	4561095
4x Laemmli Sample Buffer 10 mL	BIORAD	1610747
50 mL sterile polypropylene centrifuge tubes	VWR	89049-174
7 mL Dounce Tissue Homogenizer with Two Glass Pestles	VWR	71000-518
70 mL polycarbonate bottle assembly	Beckman Coulter Life Sciences	355622
Agar Powder	VWR	A10752
B10P Benchtop pH Meter with pH Probe	VWR	89231-664
Barnstead GenPure xCAD Plus UV/UF - TOC (bench version)	ThermoFisher Scientific	50136146
Benzonase Nuclease	MilliporeSigma	70746-3
EDTA disodium salt dihydrate 99.0-101.0%, crystals, ultrapure Bioreagent Molecular biology grade, J.T. Baker	VWR	4040-01
EmulsiFlex-C3	Avestin, Inc.
Fiberlite F13-14 x 50cy Fixed Angle Rotor	ThermoFisher Scientific	75006526
Hydrochloric acid 6.0 N	VWR	BDH7204
IBI Scientific Orbital Platform Shaker	Fischer Scientific	15-453-211
LB Broth Miller	VWR	214906
Lysozyme, Egg White, Ultra Pure Grade	VWR	VWRV0063
Magnesium chloride hexahydrate	Sigma Aldrich	M2670
NADH	Sigma Aldrich	10107735001
Optima XPN-80 - IVD	Beckman Coulter Life Sciences	A99839
Pharmco Products PURE ALCOHOL 200 PROOF GL 4/CS	Fischer Scientific	NC1624582
Phenol Solution, Equilibrated with 10 mM Tris HCl, pH 8.0, 1 mM EDTA, BioReagent, for molecular biology	Sigma - Millipore	P4557
Pierce Coomassie Plus (Bradford) Assay Kit	Thermofisher	23238
Pro-Q emerald 300 Lipopolysaccharide Gel Stain Kit	Thermofisher	P20495
Proteacease -50, EDTA free	G Biosciences	786-334
Proteinase K, Molecular Biology Grade	New England Biolabs	P8107S
Sodium hydroxide ≥99.99%	VWR	AA45780-22
Sorval RC 6 Plus Centrifuge	ThermoFisher Scientific	36-101-0816
Sucrose	MilliporeSigma	SX1075-3
SW 41 Ti Swinging-Bucket Rotor	Beckman Coulter Life Sciences	331362
Tris(hydroxymethyl)aminomethane (TRIS, Trometamol) ≥99.9% (dried basis), ultrapure Bioreagent Molecular biology grade, J.T. Baker	VWR	JT4109-6
Type 45 Ti Fixed-Angle Titanium Rotor	Beckman Coulter Life Sciences	339160
Ultra-Clear Tube ,14 x 89mm	Beckman Coulter Life Sciences	344059
Vortex-Genie 2	VWR	102091-234